Profilo
Stephen Farrand formerly worked at Merck & Co., Inc., as Vice President-Bioprocess Development from 2009 to 2015, NantKwest, Inc., as Senior Vice President-Global Manufacturing from 2015 to 2016, Schering-Plough Research Institute, as VP-Global Biologics & Sterile Product Development, and Jounce Therapeutics, Inc., as Chief Technical Officer.
Dr. Farrand received his undergraduate degree from the University of Bath and doctorate degree from the University of Leicester.
Precedenti posizioni note di Stephen Farrand
| Società | Posizione | Fine |
|---|---|---|
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/01/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2015 |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Corporate Officer/Principal | - |
| JOUNCE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Stephen Farrand
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
















